nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylpropanolamine—ADRB2—ulcerative colitis	0.633	1	CbGaD
Phenylpropanolamine—MAOA—Nicotine—ulcerative colitis	0.204	0.847	CbGbCtD
Phenylpropanolamine—CYP1A2—Nicotine—ulcerative colitis	0.0368	0.153	CbGbCtD
Phenylpropanolamine—Liver injury—Mercaptopurine—ulcerative colitis	0.00232	0.0304	CcSEcCtD
Phenylpropanolamine—Hepatocellular injury—Mercaptopurine—ulcerative colitis	0.00195	0.0256	CcSEcCtD
Phenylpropanolamine—Coordination abnormal—Nicotine—ulcerative colitis	0.00193	0.0252	CcSEcCtD
Phenylpropanolamine—Blood pressure increased—Nicotine—ulcerative colitis	0.00189	0.0248	CcSEcCtD
Phenylpropanolamine—Pseudoephedrine—IL2—ulcerative colitis	0.00183	0.353	CrCbGaD
Phenylpropanolamine—Liver injury—Azathioprine—ulcerative colitis	0.00138	0.0181	CcSEcCtD
Phenylpropanolamine—Irritability—Nicotine—ulcerative colitis	0.00131	0.0172	CcSEcCtD
Phenylpropanolamine—Liver injury—Mesalazine—ulcerative colitis	0.00126	0.0165	CcSEcCtD
Phenylpropanolamine—Hepatocellular injury—Azathioprine—ulcerative colitis	0.00116	0.0152	CcSEcCtD
Phenylpropanolamine—Hepatocellular injury—Mesalazine—ulcerative colitis	0.00106	0.0139	CcSEcCtD
Phenylpropanolamine—Psychotic disorder—Budesonide—ulcerative colitis	0.000923	0.0121	CcSEcCtD
Phenylpropanolamine—Irritability—Budesonide—ulcerative colitis	0.000902	0.0118	CcSEcCtD
Phenylpropanolamine—Flushing—Nicotine—ulcerative colitis	0.000881	0.0115	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Nicotine—ulcerative colitis	0.000848	0.0111	CcSEcCtD
Phenylpropanolamine—Tension—Nicotine—ulcerative colitis	0.000811	0.0106	CcSEcCtD
Phenylpropanolamine—Nervousness—Nicotine—ulcerative colitis	0.000803	0.0105	CcSEcCtD
Phenylpropanolamine—Tremor—Nicotine—ulcerative colitis	0.000774	0.0101	CcSEcCtD
Phenylpropanolamine—Amphetamine—SLC22A5—ulcerative colitis	0.000765	0.147	CrCbGaD
Phenylpropanolamine—Agitation—Nicotine—ulcerative colitis	0.000759	0.00995	CcSEcCtD
Phenylpropanolamine—Ephedrine—ADRB2—ulcerative colitis	0.000723	0.139	CrCbGaD
Phenylpropanolamine—Methamphetamine—SLC22A5—ulcerative colitis	0.000709	0.137	CrCbGaD
Phenylpropanolamine—Anxiety—Nicotine—ulcerative colitis	0.000701	0.00918	CcSEcCtD
Phenylpropanolamine—Confusional state—Nicotine—ulcerative colitis	0.00068	0.00891	CcSEcCtD
Phenylpropanolamine—Euphoric mood—Prednisolone—ulcerative colitis	0.000662	0.00867	CcSEcCtD
Phenylpropanolamine—Tachycardia—Nicotine—ulcerative colitis	0.000658	0.00862	CcSEcCtD
Phenylpropanolamine—Euphoric mood—Hydrocortisone—ulcerative colitis	0.000647	0.00847	CcSEcCtD
Phenylpropanolamine—Hypotension—Nicotine—ulcerative colitis	0.00063	0.00825	CcSEcCtD
Phenylpropanolamine—Pseudoephedrine—TNF—ulcerative colitis	0.000618	0.119	CrCbGaD
Phenylpropanolamine—Insomnia—Nicotine—ulcerative colitis	0.00061	0.00799	CcSEcCtD
Phenylpropanolamine—Euphoric mood—Triamcinolone—ulcerative colitis	0.000609	0.00798	CcSEcCtD
Phenylpropanolamine—Euphoric mood—Methylprednisolone—ulcerative colitis	0.000608	0.00796	CcSEcCtD
Phenylpropanolamine—Flushing—Budesonide—ulcerative colitis	0.000607	0.00795	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Nicotine—ulcerative colitis	0.000601	0.00788	CcSEcCtD
Phenylpropanolamine—Somnolence—Nicotine—ulcerative colitis	0.0006	0.00785	CcSEcCtD
Phenylpropanolamine—Constipation—Nicotine—ulcerative colitis	0.000577	0.00755	CcSEcCtD
Phenylpropanolamine—Tension—Budesonide—ulcerative colitis	0.000559	0.00731	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Nicotine—ulcerative colitis	0.000556	0.00728	CcSEcCtD
Phenylpropanolamine—Nervousness—Budesonide—ulcerative colitis	0.000553	0.00724	CcSEcCtD
Phenylpropanolamine—Euphoric mood—Dexamethasone—ulcerative colitis	0.000553	0.00724	CcSEcCtD
Phenylpropanolamine—Euphoric mood—Betamethasone—ulcerative colitis	0.000553	0.00724	CcSEcCtD
Phenylpropanolamine—Pseudoephedrine—ADRB2—ulcerative colitis	0.000548	0.105	CrCbGaD
Phenylpropanolamine—Vision blurred—Budesonide—ulcerative colitis	0.000536	0.00702	CcSEcCtD
Phenylpropanolamine—Psychotic disorder—Hydrocortisone—ulcerative colitis	0.000534	0.00699	CcSEcCtD
Phenylpropanolamine—Tremor—Budesonide—ulcerative colitis	0.000533	0.00698	CcSEcCtD
Phenylpropanolamine—Agitation—Budesonide—ulcerative colitis	0.000523	0.00685	CcSEcCtD
Phenylpropanolamine—Irritability—Hydrocortisone—ulcerative colitis	0.000522	0.00683	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Azathioprine—ulcerative colitis	0.000521	0.00683	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Mercaptopurine—ulcerative colitis	0.000513	0.00672	CcSEcCtD
Phenylpropanolamine—Psychotic disorder—Methylprednisolone—ulcerative colitis	0.000501	0.00657	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Nicotine—ulcerative colitis	0.000497	0.00651	CcSEcCtD
Phenylpropanolamine—Irritability—Methylprednisolone—ulcerative colitis	0.00049	0.00642	CcSEcCtD
Phenylpropanolamine—Anxiety—Budesonide—ulcerative colitis	0.000483	0.00632	CcSEcCtD
Phenylpropanolamine—Euphoric mood—Prednisone—ulcerative colitis	0.000481	0.0063	CcSEcCtD
Phenylpropanolamine—Confusional state—Budesonide—ulcerative colitis	0.000468	0.00613	CcSEcCtD
Phenylpropanolamine—Psychotic disorder—Betamethasone—ulcerative colitis	0.000456	0.00597	CcSEcCtD
Phenylpropanolamine—Psychotic disorder—Dexamethasone—ulcerative colitis	0.000456	0.00597	CcSEcCtD
Phenylpropanolamine—Tension—Mesalazine—ulcerative colitis	0.000454	0.00595	CcSEcCtD
Phenylpropanolamine—Tachycardia—Budesonide—ulcerative colitis	0.000453	0.00594	CcSEcCtD
Phenylpropanolamine—Nervousness—Mesalazine—ulcerative colitis	0.00045	0.00589	CcSEcCtD
Phenylpropanolamine—Dizziness—Nicotine—ulcerative colitis	0.000446	0.00584	CcSEcCtD
Phenylpropanolamine—Irritability—Dexamethasone—ulcerative colitis	0.000446	0.00584	CcSEcCtD
Phenylpropanolamine—Irritability—Betamethasone—ulcerative colitis	0.000446	0.00584	CcSEcCtD
Phenylpropanolamine—Vomiting—Mercaptopurine—ulcerative colitis	0.000443	0.0058	CcSEcCtD
Phenylpropanolamine—Rash—Mercaptopurine—ulcerative colitis	0.000439	0.00575	CcSEcCtD
Phenylpropanolamine—Dermatitis—Mercaptopurine—ulcerative colitis	0.000438	0.00574	CcSEcCtD
Phenylpropanolamine—Vision blurred—Mesalazine—ulcerative colitis	0.000436	0.00571	CcSEcCtD
Phenylpropanolamine—Tremor—Mesalazine—ulcerative colitis	0.000434	0.00568	CcSEcCtD
Phenylpropanolamine—Vomiting—Nicotine—ulcerative colitis	0.000429	0.00562	CcSEcCtD
Phenylpropanolamine—Rash—Nicotine—ulcerative colitis	0.000425	0.00557	CcSEcCtD
Phenylpropanolamine—Dermatitis—Nicotine—ulcerative colitis	0.000425	0.00556	CcSEcCtD
Phenylpropanolamine—Insomnia—Budesonide—ulcerative colitis	0.00042	0.0055	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Budesonide—ulcerative colitis	0.000414	0.00542	CcSEcCtD
Phenylpropanolamine—Nausea—Mercaptopurine—ulcerative colitis	0.000413	0.00541	CcSEcCtD
Phenylpropanolamine—Somnolence—Budesonide—ulcerative colitis	0.000413	0.00541	CcSEcCtD
Phenylpropanolamine—Nausea—Nicotine—ulcerative colitis	0.000401	0.00525	CcSEcCtD
Phenylpropanolamine—Constipation—Budesonide—ulcerative colitis	0.000397	0.0052	CcSEcCtD
Phenylpropanolamine—Psychotic disorder—Prednisone—ulcerative colitis	0.000397	0.0052	CcSEcCtD
Phenylpropanolamine—Anxiety—Mesalazine—ulcerative colitis	0.000393	0.00514	CcSEcCtD
Phenylpropanolamine—Irritability—Prednisone—ulcerative colitis	0.000388	0.00508	CcSEcCtD
Phenylpropanolamine—Hypotension—Azathioprine—ulcerative colitis	0.000388	0.00508	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Budesonide—ulcerative colitis	0.000383	0.00501	CcSEcCtD
Phenylpropanolamine—Confusional state—Mesalazine—ulcerative colitis	0.000381	0.00499	CcSEcCtD
Phenylpropanolamine—Hallucination—Hydrocortisone—ulcerative colitis	0.000376	0.00493	CcSEcCtD
Phenylpropanolamine—Tachycardia—Mesalazine—ulcerative colitis	0.000369	0.00483	CcSEcCtD
Phenylpropanolamine—Hallucination—Methylprednisolone—ulcerative colitis	0.000353	0.00463	CcSEcCtD
Phenylpropanolamine—Hypotension—Mesalazine—ulcerative colitis	0.000353	0.00462	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Prednisolone—ulcerative colitis	0.000346	0.00453	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Budesonide—ulcerative colitis	0.000342	0.00448	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Azathioprine—ulcerative colitis	0.000342	0.00448	CcSEcCtD
Phenylpropanolamine—Insomnia—Mesalazine—ulcerative colitis	0.000342	0.00447	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Hydrocortisone—ulcerative colitis	0.000338	0.00442	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Mesalazine—ulcerative colitis	0.000337	0.00441	CcSEcCtD
Phenylpropanolamine—Somnolence—Mesalazine—ulcerative colitis	0.000336	0.0044	CcSEcCtD
Phenylpropanolamine—Constipation—Mesalazine—ulcerative colitis	0.000323	0.00423	CcSEcCtD
Phenylpropanolamine—Hallucination—Betamethasone—ulcerative colitis	0.000321	0.00421	CcSEcCtD
Phenylpropanolamine—Hallucination—Dexamethasone—ulcerative colitis	0.000321	0.00421	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Triamcinolone—ulcerative colitis	0.000318	0.00417	CcSEcCtD
Phenylpropanolamine—Vision blurred—Prednisolone—ulcerative colitis	0.000318	0.00416	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Methylprednisolone—ulcerative colitis	0.000317	0.00416	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Mesalazine—ulcerative colitis	0.000311	0.00408	CcSEcCtD
Phenylpropanolamine—Dizziness—Budesonide—ulcerative colitis	0.000307	0.00402	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Azathioprine—ulcerative colitis	0.000306	0.004	CcSEcCtD
Phenylpropanolamine—Vomiting—Budesonide—ulcerative colitis	0.000295	0.00387	CcSEcCtD
Phenylpropanolamine—Rash—Budesonide—ulcerative colitis	0.000293	0.00384	CcSEcCtD
Phenylpropanolamine—Dermatitis—Budesonide—ulcerative colitis	0.000293	0.00383	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Betamethasone—ulcerative colitis	0.000289	0.00378	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Dexamethasone—ulcerative colitis	0.000289	0.00378	CcSEcCtD
Phenylpropanolamine—Hallucination—Prednisone—ulcerative colitis	0.00028	0.00367	CcSEcCtD
Phenylpropanolamine—Anxiety—Hydrocortisone—ulcerative colitis	0.000279	0.00366	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Mesalazine—ulcerative colitis	0.000278	0.00365	CcSEcCtD
Phenylpropanolamine—Nausea—Budesonide—ulcerative colitis	0.000276	0.00361	CcSEcCtD
Phenylpropanolamine—Dizziness—Azathioprine—ulcerative colitis	0.000274	0.00359	CcSEcCtD
Phenylpropanolamine—Tachycardia—Prednisolone—ulcerative colitis	0.000268	0.00352	CcSEcCtD
Phenylpropanolamine—Vomiting—Azathioprine—ulcerative colitis	0.000264	0.00345	CcSEcCtD
Phenylpropanolamine—Anxiety—Methylprednisolone—ulcerative colitis	0.000262	0.00344	CcSEcCtD
Phenylpropanolamine—Tachycardia—Hydrocortisone—ulcerative colitis	0.000262	0.00343	CcSEcCtD
Phenylpropanolamine—Rash—Azathioprine—ulcerative colitis	0.000261	0.00342	CcSEcCtD
Phenylpropanolamine—Dermatitis—Azathioprine—ulcerative colitis	0.000261	0.00342	CcSEcCtD
Phenylpropanolamine—Flushing—Prednisone—ulcerative colitis	0.000261	0.00342	CcSEcCtD
Phenylpropanolamine—Confusional state—Methylprednisolone—ulcerative colitis	0.000254	0.00333	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Prednisone—ulcerative colitis	0.000251	0.00329	CcSEcCtD
Phenylpropanolamine—Hypotension—Hydrocortisone—ulcerative colitis	0.000251	0.00329	CcSEcCtD
Phenylpropanolamine—Dizziness—Mesalazine—ulcerative colitis	0.00025	0.00327	CcSEcCtD
Phenylpropanolamine—Insomnia—Prednisolone—ulcerative colitis	0.000249	0.00326	CcSEcCtD
Phenylpropanolamine—Tachycardia—Triamcinolone—ulcerative colitis	0.000247	0.00323	CcSEcCtD
Phenylpropanolamine—Nausea—Azathioprine—ulcerative colitis	0.000246	0.00323	CcSEcCtD
Phenylpropanolamine—Tachycardia—Methylprednisolone—ulcerative colitis	0.000246	0.00323	CcSEcCtD
Phenylpropanolamine—Insomnia—Hydrocortisone—ulcerative colitis	0.000243	0.00318	CcSEcCtD
Phenylpropanolamine—Vomiting—Mesalazine—ulcerative colitis	0.00024	0.00315	CcSEcCtD
Phenylpropanolamine—Anxiety—Dexamethasone—ulcerative colitis	0.000239	0.00312	CcSEcCtD
Phenylpropanolamine—Anxiety—Betamethasone—ulcerative colitis	0.000239	0.00312	CcSEcCtD
Phenylpropanolamine—Rash—Mesalazine—ulcerative colitis	0.000238	0.00312	CcSEcCtD
Phenylpropanolamine—Dermatitis—Mesalazine—ulcerative colitis	0.000238	0.00312	CcSEcCtD
Phenylpropanolamine—Hypotension—Methylprednisolone—ulcerative colitis	0.000236	0.00309	CcSEcCtD
Phenylpropanolamine—Vision blurred—Prednisone—ulcerative colitis	0.000231	0.00302	CcSEcCtD
Phenylpropanolamine—Insomnia—Triamcinolone—ulcerative colitis	0.000229	0.003	CcSEcCtD
Phenylpropanolamine—Insomnia—Methylprednisolone—ulcerative colitis	0.000228	0.00299	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Prednisolone—ulcerative colitis	0.000227	0.00297	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Triamcinolone—ulcerative colitis	0.000226	0.00295	CcSEcCtD
Phenylpropanolamine—Agitation—Prednisone—ulcerative colitis	0.000225	0.00295	CcSEcCtD
Phenylpropanolamine—Nausea—Mesalazine—ulcerative colitis	0.000224	0.00294	CcSEcCtD
Phenylpropanolamine—Tachycardia—Dexamethasone—ulcerative colitis	0.000224	0.00293	CcSEcCtD
Phenylpropanolamine—Tachycardia—Betamethasone—ulcerative colitis	0.000224	0.00293	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Hydrocortisone—ulcerative colitis	0.000221	0.0029	CcSEcCtD
Phenylpropanolamine—Hypotension—Betamethasone—ulcerative colitis	0.000214	0.00281	CcSEcCtD
Phenylpropanolamine—Hypotension—Dexamethasone—ulcerative colitis	0.000214	0.00281	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Triamcinolone—ulcerative colitis	0.000208	0.00273	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Methylprednisolone—ulcerative colitis	0.000208	0.00272	CcSEcCtD
Phenylpropanolamine—Anxiety—Prednisone—ulcerative colitis	0.000208	0.00272	CcSEcCtD
Phenylpropanolamine—Insomnia—Betamethasone—ulcerative colitis	0.000208	0.00272	CcSEcCtD
Phenylpropanolamine—Insomnia—Dexamethasone—ulcerative colitis	0.000208	0.00272	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Prednisolone—ulcerative colitis	0.000203	0.00265	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Hydrocortisone—ulcerative colitis	0.000198	0.00259	CcSEcCtD
Phenylpropanolamine—Tachycardia—Prednisone—ulcerative colitis	0.000195	0.00255	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Dexamethasone—ulcerative colitis	0.000189	0.00248	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Betamethasone—ulcerative colitis	0.000189	0.00248	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Triamcinolone—ulcerative colitis	0.000186	0.00244	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Methylprednisolone—ulcerative colitis	0.000186	0.00244	CcSEcCtD
Phenylpropanolamine—Dizziness—Prednisolone—ulcerative colitis	0.000182	0.00238	CcSEcCtD
Phenylpropanolamine—Insomnia—Prednisone—ulcerative colitis	0.000181	0.00237	CcSEcCtD
Phenylpropanolamine—Dizziness—Hydrocortisone—ulcerative colitis	0.000178	0.00233	CcSEcCtD
Phenylpropanolamine—Rash—Prednisolone—ulcerative colitis	0.000173	0.00227	CcSEcCtD
Phenylpropanolamine—Dermatitis—Prednisolone—ulcerative colitis	0.000173	0.00227	CcSEcCtD
Phenylpropanolamine—Constipation—Prednisone—ulcerative colitis	0.000171	0.00224	CcSEcCtD
Phenylpropanolamine—Vomiting—Hydrocortisone—ulcerative colitis	0.000171	0.00224	CcSEcCtD
Phenylpropanolamine—Rash—Hydrocortisone—ulcerative colitis	0.000169	0.00222	CcSEcCtD
Phenylpropanolamine—Dermatitis—Hydrocortisone—ulcerative colitis	0.000169	0.00222	CcSEcCtD
Phenylpropanolamine—Dizziness—Triamcinolone—ulcerative colitis	0.000167	0.00219	CcSEcCtD
Phenylpropanolamine—Dizziness—Methylprednisolone—ulcerative colitis	0.000167	0.00219	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Prednisone—ulcerative colitis	0.000165	0.00216	CcSEcCtD
Phenylpropanolamine—Nausea—Prednisolone—ulcerative colitis	0.000163	0.00214	CcSEcCtD
Phenylpropanolamine—Vomiting—Triamcinolone—ulcerative colitis	0.000161	0.00211	CcSEcCtD
Phenylpropanolamine—Vomiting—Methylprednisolone—ulcerative colitis	0.00016	0.0021	CcSEcCtD
Phenylpropanolamine—Nausea—Hydrocortisone—ulcerative colitis	0.00016	0.00209	CcSEcCtD
Phenylpropanolamine—Rash—Triamcinolone—ulcerative colitis	0.000159	0.00209	CcSEcCtD
Phenylpropanolamine—Dermatitis—Triamcinolone—ulcerative colitis	0.000159	0.00209	CcSEcCtD
Phenylpropanolamine—Rash—Methylprednisolone—ulcerative colitis	0.000159	0.00208	CcSEcCtD
Phenylpropanolamine—Dermatitis—Methylprednisolone—ulcerative colitis	0.000159	0.00208	CcSEcCtD
Phenylpropanolamine—Dizziness—Dexamethasone—ulcerative colitis	0.000152	0.00199	CcSEcCtD
Phenylpropanolamine—Dizziness—Betamethasone—ulcerative colitis	0.000152	0.00199	CcSEcCtD
Phenylpropanolamine—Nausea—Triamcinolone—ulcerative colitis	0.00015	0.00197	CcSEcCtD
Phenylpropanolamine—Nausea—Methylprednisolone—ulcerative colitis	0.00015	0.00196	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Prednisone—ulcerative colitis	0.000147	0.00193	CcSEcCtD
Phenylpropanolamine—Vomiting—Betamethasone—ulcerative colitis	0.000146	0.00191	CcSEcCtD
Phenylpropanolamine—Vomiting—Dexamethasone—ulcerative colitis	0.000146	0.00191	CcSEcCtD
Phenylpropanolamine—Rash—Dexamethasone—ulcerative colitis	0.000145	0.0019	CcSEcCtD
Phenylpropanolamine—Rash—Betamethasone—ulcerative colitis	0.000145	0.0019	CcSEcCtD
Phenylpropanolamine—Dermatitis—Betamethasone—ulcerative colitis	0.000145	0.00189	CcSEcCtD
Phenylpropanolamine—Dermatitis—Dexamethasone—ulcerative colitis	0.000145	0.00189	CcSEcCtD
Phenylpropanolamine—Nausea—Dexamethasone—ulcerative colitis	0.000136	0.00179	CcSEcCtD
Phenylpropanolamine—Nausea—Betamethasone—ulcerative colitis	0.000136	0.00179	CcSEcCtD
Phenylpropanolamine—Dizziness—Prednisone—ulcerative colitis	0.000132	0.00173	CcSEcCtD
Phenylpropanolamine—Vomiting—Prednisone—ulcerative colitis	0.000127	0.00166	CcSEcCtD
Phenylpropanolamine—Rash—Prednisone—ulcerative colitis	0.000126	0.00165	CcSEcCtD
Phenylpropanolamine—Dermatitis—Prednisone—ulcerative colitis	0.000126	0.00165	CcSEcCtD
Phenylpropanolamine—Nausea—Prednisone—ulcerative colitis	0.000119	0.00155	CcSEcCtD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—CXCR2—ulcerative colitis	3.78e-05	0.000851	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—GNA12—ulcerative colitis	3.7e-05	0.000835	CbGpPWpGaD
Phenylpropanolamine—DRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	3.66e-05	0.000824	CbGpPWpGaD
Phenylpropanolamine—MAOA—SIDS Susceptibility Pathways—IL6—ulcerative colitis	3.63e-05	0.000817	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—GNA12—ulcerative colitis	3.62e-05	0.000816	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Platelet activation, signaling and aggregation—JAK2—ulcerative colitis	3.58e-05	0.000806	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—CCL20—ulcerative colitis	3.58e-05	0.000806	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—GHRL—ulcerative colitis	3.57e-05	0.000806	CbGpPWpGaD
Phenylpropanolamine—SLC6A3—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	3.56e-05	0.000803	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—CXCR1—ulcerative colitis	3.56e-05	0.000802	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—CCR6—ulcerative colitis	3.55e-05	0.000801	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—GHRL—ulcerative colitis	3.54e-05	0.000798	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—CXCR2—ulcerative colitis	3.51e-05	0.000791	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—PTGER4—ulcerative colitis	3.51e-05	0.000791	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—CALM3—ulcerative colitis	3.46e-05	0.00078	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—GHRL—ulcerative colitis	3.46e-05	0.00078	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—PTGER4—ulcerative colitis	3.43e-05	0.000774	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—CXCR2—ulcerative colitis	3.43e-05	0.000773	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—GNA12—ulcerative colitis	3.36e-05	0.000758	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—CCR6—ulcerative colitis	3.3e-05	0.000744	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	3.29e-05	0.000741	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—ADRB2—ulcerative colitis	3.26e-05	0.000734	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—CCR6—ulcerative colitis	3.23e-05	0.000727	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	3.22e-05	0.000725	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—GHRL—ulcerative colitis	3.21e-05	0.000724	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CXCR1—ulcerative colitis	3.2e-05	0.000721	CbGpPWpGaD
Phenylpropanolamine—DRD1—Circadian rythm related genes—TP53—ulcerative colitis	3.2e-05	0.000721	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—CXCR2—ulcerative colitis	3.19e-05	0.000718	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—SEL1L—ulcerative colitis	3.15e-05	0.000709	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—GHRL—ulcerative colitis	3.14e-05	0.000708	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CXCR1—ulcerative colitis	3.13e-05	0.000706	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—PTGER4—ulcerative colitis	3.13e-05	0.000705	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—CCL20—ulcerative colitis	3.13e-05	0.000705	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Platelet activation, signaling and aggregation—IL2—ulcerative colitis	3.12e-05	0.000703	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—CALM3—ulcerative colitis	3.11e-05	0.000701	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—G alpha (i) signalling events—CXCL8—ulcerative colitis	3.11e-05	0.000701	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—CALM3—ulcerative colitis	3.04e-05	0.000686	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—CCR6—ulcerative colitis	3e-05	0.000675	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—ADRB2—ulcerative colitis	2.96e-05	0.000667	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—GNA12—ulcerative colitis	2.94e-05	0.000662	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—ADRB2—ulcerative colitis	2.93e-05	0.00066	CbGpPWpGaD
Phenylpropanolamine—DRD1—Circadian rythm related genes—IL6—ulcerative colitis	2.93e-05	0.00066	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—SEL1L—ulcerative colitis	2.92e-05	0.000659	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—PTGER4—ulcerative colitis	2.91e-05	0.000655	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—GHRL—ulcerative colitis	2.86e-05	0.000645	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—PTGER4—ulcerative colitis	2.84e-05	0.00064	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CCL20—ulcerative colitis	2.81e-05	0.000633	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—CXCR2—ulcerative colitis	2.79e-05	0.000628	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR ligand binding—CXCL8—ulcerative colitis	2.78e-05	0.000628	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—ADCY5—ulcerative colitis	2.77e-05	0.000623	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CCL20—ulcerative colitis	2.75e-05	0.00062	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—PTGS1—ulcerative colitis	2.75e-05	0.000619	CbGpPWpGaD
Phenylpropanolamine—SLC6A2—Transmembrane transport of small molecules—ALB—ulcerative colitis	2.7e-05	0.000608	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—GHRL—ulcerative colitis	2.66e-05	0.0006	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—ADRB2—ulcerative colitis	2.66e-05	0.000599	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	2.66e-05	0.000599	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—GNA12—ulcerative colitis	2.64e-05	0.000596	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—PTGER4—ulcerative colitis	2.64e-05	0.000595	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—CCR6—ulcerative colitis	2.62e-05	0.00059	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Hemostasis—MMP1—ulcerative colitis	2.62e-05	0.00059	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—GHRL—ulcerative colitis	2.6e-05	0.000586	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CXCR1—ulcerative colitis	2.59e-05	0.000584	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—GNA12—ulcerative colitis	2.58e-05	0.000583	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—CALM3—ulcerative colitis	2.52e-05	0.000568	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—ADCY5—ulcerative colitis	2.51e-05	0.000566	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CXCR2—ulcerative colitis	2.51e-05	0.000565	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR ligand binding—CXCL8—ulcerative colitis	2.5e-05	0.000564	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—ADCY5—ulcerative colitis	2.49e-05	0.00056	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—MAML2—ulcerative colitis	2.48e-05	0.00056	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—CALM3—ulcerative colitis	2.47e-05	0.000558	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	2.47e-05	0.000557	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CXCR2—ulcerative colitis	2.45e-05	0.000552	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR ligand binding—CXCL8—ulcerative colitis	2.45e-05	0.000552	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—ulcerative colitis	2.43e-05	0.000549	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—ADCY5—ulcerative colitis	2.43e-05	0.000548	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—CHP1—ulcerative colitis	2.43e-05	0.000547	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—GHRL—ulcerative colitis	2.42e-05	0.000544	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CXCR1—ulcerative colitis	2.41e-05	0.000542	CbGpPWpGaD
Phenylpropanolamine—SLC6A3—Transmembrane transport of small molecules—ALB—ulcerative colitis	2.39e-05	0.000538	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—ADRB2—ulcerative colitis	2.37e-05	0.000534	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CCR6—ulcerative colitis	2.36e-05	0.000531	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—CALM3—ulcerative colitis	2.34e-05	0.000527	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—PTGER4—ulcerative colitis	2.31e-05	0.00052	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CCR6—ulcerative colitis	2.3e-05	0.000519	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	2.28e-05	0.000513	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CCL20—ulcerative colitis	2.27e-05	0.000512	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—ADCY5—ulcerative colitis	2.26e-05	0.000509	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—MAML2—ulcerative colitis	2.23e-05	0.000503	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—ADCY5—ulcerative colitis	2.21e-05	0.000498	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—ADRB2—ulcerative colitis	2.2e-05	0.000496	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—MAML2—ulcerative colitis	2.18e-05	0.000492	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—ADRB2—ulcerative colitis	2.15e-05	0.000485	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—GNA12—ulcerative colitis	2.14e-05	0.000482	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CCL20—ulcerative colitis	2.11e-05	0.000476	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—GHRL—ulcerative colitis	2.11e-05	0.000476	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—DLD—ulcerative colitis	2.1e-05	0.000472	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—PTGER4—ulcerative colitis	2.07e-05	0.000467	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—CALM3—ulcerative colitis	2.05e-05	0.000461	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—PTGER4—ulcerative colitis	2.03e-05	0.000457	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CXCR2—ulcerative colitis	2.03e-05	0.000457	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR ligand binding—CXCL8—ulcerative colitis	2.03e-05	0.000457	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	2.02e-05	0.000455	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—RIPK2—ulcerative colitis	2.01e-05	0.000454	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—ADCY5—ulcerative colitis	2.01e-05	0.000453	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—ADRB2—ulcerative colitis	2e-05	0.000451	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—GNA12—ulcerative colitis	1.99e-05	0.000448	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Hemostasis—ALB—ulcerative colitis	1.98e-05	0.000447	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—ABCB1—ulcerative colitis	1.92e-05	0.000434	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CCR6—ulcerative colitis	1.91e-05	0.000429	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—GHRL—ulcerative colitis	1.9e-05	0.000428	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CXCR2—ulcerative colitis	1.88e-05	0.000424	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR ligand binding—CXCL8—ulcerative colitis	1.88e-05	0.000424	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—ADCY5—ulcerative colitis	1.87e-05	0.000421	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—GHRL—ulcerative colitis	1.86e-05	0.000419	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Hemostasis—JAK2—ulcerative colitis	1.84e-05	0.000416	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CALM3—ulcerative colitis	1.84e-05	0.000414	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—PTGS1—ulcerative colitis	1.84e-05	0.000414	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—ADCY5—ulcerative colitis	1.83e-05	0.000412	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—RIPK2—ulcerative colitis	1.81e-05	0.000408	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—MAML2—ulcerative colitis	1.81e-05	0.000407	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CALM3—ulcerative colitis	1.8e-05	0.000405	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—ADCY5—ulcerative colitis	1.8e-05	0.000405	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—RIPK2—ulcerative colitis	1.77e-05	0.000399	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CCR6—ulcerative colitis	1.77e-05	0.000399	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—ADRB2—ulcerative colitis	1.75e-05	0.000394	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—JAK2—ulcerative colitis	1.72e-05	0.000389	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—ADCY5—ulcerative colitis	1.7e-05	0.000383	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—MAML2—ulcerative colitis	1.68e-05	0.000378	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—PTGER4—ulcerative colitis	1.68e-05	0.000378	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—CALM3—ulcerative colitis	1.65e-05	0.000373	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Hemostasis—IL2—ulcerative colitis	1.61e-05	0.000362	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—CXCL8—ulcerative colitis	1.57e-05	0.000355	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—ADRB2—ulcerative colitis	1.57e-05	0.000354	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—JAK2—ulcerative colitis	1.57e-05	0.000353	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—PTGER4—ulcerative colitis	1.56e-05	0.000351	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—JAK2—ulcerative colitis	1.55e-05	0.000349	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—GHRL—ulcerative colitis	1.54e-05	0.000346	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—JAK2—ulcerative colitis	1.52e-05	0.000342	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—IL2—ulcerative colitis	1.5e-05	0.000339	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CALM3—ulcerative colitis	1.49e-05	0.000335	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—ADCY5—ulcerative colitis	1.48e-05	0.000334	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—RIPK2—ulcerative colitis	1.47e-05	0.00033	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—CXCL8—ulcerative colitis	1.43e-05	0.000322	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—GHRL—ulcerative colitis	1.43e-05	0.000322	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—CXCL8—ulcerative colitis	1.41e-05	0.000319	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—JAK2—ulcerative colitis	1.41e-05	0.000317	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—CXCL8—ulcerative colitis	1.38e-05	0.000312	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CALM3—ulcerative colitis	1.38e-05	0.000312	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—JAK2—ulcerative colitis	1.38e-05	0.00031	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—IL2—ulcerative colitis	1.37e-05	0.000308	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—RIPK2—ulcerative colitis	1.36e-05	0.000307	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—IL2—ulcerative colitis	1.35e-05	0.000305	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—PPARG—ulcerative colitis	1.34e-05	0.000302	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—ADCY5—ulcerative colitis	1.33e-05	0.000301	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—IL2—ulcerative colitis	1.32e-05	0.000298	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—ADCY5—ulcerative colitis	1.3e-05	0.000294	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—ABCB1—ulcerative colitis	1.29e-05	0.00029	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—CXCL8—ulcerative colitis	1.28e-05	0.00029	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—ADRB2—ulcerative colitis	1.27e-05	0.000287	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—CXCL8—ulcerative colitis	1.26e-05	0.000283	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Hemostasis—TGFB1—ulcerative colitis	1.25e-05	0.000283	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—JAK2—ulcerative colitis	1.25e-05	0.000283	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—IL2—ulcerative colitis	1.23e-05	0.000277	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—ALB—ulcerative colitis	1.2e-05	0.000271	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—IL2—ulcerative colitis	1.2e-05	0.000271	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—ADCY5—ulcerative colitis	1.2e-05	0.00027	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—ADRB2—ulcerative colitis	1.18e-05	0.000266	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—JAK2—ulcerative colitis	1.17e-05	0.000263	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—CXCL8—ulcerative colitis	1.14e-05	0.000258	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—JAK2—ulcerative colitis	1.14e-05	0.000257	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.11e-05	0.00025	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—IL2—ulcerative colitis	1.09e-05	0.000247	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—ADCY5—ulcerative colitis	1.08e-05	0.000243	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—CXCL8—ulcerative colitis	1.06e-05	0.00024	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—JAK2—ulcerative colitis	1.06e-05	0.000238	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—PTGS2—ulcerative colitis	1.05e-05	0.000237	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—CXCL8—ulcerative colitis	1.04e-05	0.000234	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Hemostasis—TP53—ulcerative colitis	1.03e-05	0.000233	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—IL2—ulcerative colitis	1.02e-05	0.000229	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—PTGS1—ulcerative colitis	1.01e-05	0.000228	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—ADCY5—ulcerative colitis	1e-05	0.000226	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	9.97e-06	0.000225	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—IL2—ulcerative colitis	9.93e-06	0.000224	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—CXCL8—ulcerative colitis	9.66e-06	0.000218	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—JAK2—ulcerative colitis	9.25e-06	0.000208	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—IL2—ulcerative colitis	9.23e-06	0.000208	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—CALM3—ulcerative colitis	9.13e-06	0.000206	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—RELA—ulcerative colitis	8.96e-06	0.000202	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—PPARG—ulcerative colitis	8.94e-06	0.000202	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	8.72e-06	0.000197	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—CXCL8—ulcerative colitis	8.44e-06	0.00019	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—JAK2—ulcerative colitis	8.32e-06	0.000187	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—JAK2—ulcerative colitis	8.13e-06	0.000183	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—IL2—ulcerative colitis	8.07e-06	0.000182	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—RELA—ulcerative colitis	8.05e-06	0.000181	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—ALB—ulcerative colitis	8.04e-06	0.000181	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—IL6—ulcerative colitis	8.03e-06	0.000181	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—RELA—ulcerative colitis	7.88e-06	0.000178	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—MMP9—ulcerative colitis	7.64e-06	0.000172	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CXCL8—ulcerative colitis	7.59e-06	0.000171	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—NFKB1—ulcerative colitis	7.55e-06	0.00017	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CXCL8—ulcerative colitis	7.42e-06	0.000167	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—IL2—ulcerative colitis	7.25e-06	0.000163	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—IL6—ulcerative colitis	7.22e-06	0.000163	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—ABCB1—ulcerative colitis	7.1e-06	0.00016	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—IL2—ulcerative colitis	7.1e-06	0.00016	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—IL6—ulcerative colitis	7.06e-06	0.000159	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—PTGS2—ulcerative colitis	7.04e-06	0.000159	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—MMP9—ulcerative colitis	6.86e-06	0.000155	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—NFKB1—ulcerative colitis	6.79e-06	0.000153	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—STAT3—ulcerative colitis	6.79e-06	0.000153	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—JAK2—ulcerative colitis	6.73e-06	0.000152	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—MMP9—ulcerative colitis	6.72e-06	0.000151	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—NFKB1—ulcerative colitis	6.64e-06	0.00015	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—ADCY5—ulcerative colitis	6.62e-06	0.000149	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—RELA—ulcerative colitis	6.52e-06	0.000147	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—TGFB1—ulcerative colitis	6.29e-06	0.000142	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—JAK2—ulcerative colitis	6.25e-06	0.000141	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CXCL8—ulcerative colitis	6.14e-06	0.000138	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—STAT3—ulcerative colitis	6.1e-06	0.000138	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—RELA—ulcerative colitis	6.05e-06	0.000136	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—STAT3—ulcerative colitis	5.97e-06	0.000135	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—IL2—ulcerative colitis	5.87e-06	0.000132	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—IL6—ulcerative colitis	5.84e-06	0.000132	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CXCL8—ulcerative colitis	5.71e-06	0.000129	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—TGFB1—ulcerative colitis	5.66e-06	0.000128	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—MMP9—ulcerative colitis	5.55e-06	0.000125	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—TGFB1—ulcerative colitis	5.53e-06	0.000125	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—NFKB1—ulcerative colitis	5.5e-06	0.000124	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—IL2—ulcerative colitis	5.45e-06	0.000123	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—IL6—ulcerative colitis	5.43e-06	0.000122	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—TP53—ulcerative colitis	5.18e-06	0.000117	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—MMP9—ulcerative colitis	5.16e-06	0.000116	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—NFKB1—ulcerative colitis	5.11e-06	0.000115	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—STAT3—ulcerative colitis	4.94e-06	0.000111	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—PPARG—ulcerative colitis	4.94e-06	0.000111	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—IL6—ulcerative colitis	4.74e-06	0.000107	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—TP53—ulcerative colitis	4.66e-06	0.000105	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—STAT3—ulcerative colitis	4.59e-06	0.000103	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—TGFB1—ulcerative colitis	4.58e-06	0.000103	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—TP53—ulcerative colitis	4.56e-06	0.000103	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—ALB—ulcerative colitis	4.44e-06	0.0001	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—IL6—ulcerative colitis	4.26e-06	9.61e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—TGFB1—ulcerative colitis	4.25e-06	9.59e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—IL6—ulcerative colitis	4.17e-06	9.4e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—PTGS2—ulcerative colitis	3.88e-06	8.75e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—TP53—ulcerative colitis	3.77e-06	8.49e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—TP53—ulcerative colitis	3.5e-06	7.89e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—IL6—ulcerative colitis	3.45e-06	7.77e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—IL6—ulcerative colitis	3.21e-06	7.22e-05	CbGpPWpGaD
